These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9224416)
1. The effect of ganciclovir on herpes simplex virus-mediated oncolysis. Carroll NM; Chase M; Chiocca EA; Tanabe KK J Surg Res; 1997 May; 69(2):413-7. PubMed ID: 9224416 [TBL] [Abstract][Full Text] [Related]
2. HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma. Moriuchi S; Krisky DM; Marconi PC; Tamura M; Shimizu K; Yoshimine T; Cohen JB; Glorioso JC Gene Ther; 2000 Sep; 7(17):1483-90. PubMed ID: 11001368 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Boviatsis EJ; Park JS; Sena-Esteves M; Kramm CM; Chase M; Efird JT; Wei MX; Breakefield XO; Chiocca EA Cancer Res; 1994 Nov; 54(22):5745-51. PubMed ID: 7954393 [TBL] [Abstract][Full Text] [Related]
4. Purified herpes simplex virus thymidine kinase retroviral particles: III. Characterization of bystander killing mechanisms in transfected tumor cells. Burrows FJ; Gore M; Smiley WR; Kanemitsu MY; Jolly DJ; Read SB; Nicholas T; Kruse CA Cancer Gene Ther; 2002 Jan; 9(1):87-95. PubMed ID: 11916247 [TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo. Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477 [TBL] [Abstract][Full Text] [Related]
6. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy. Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036 [TBL] [Abstract][Full Text] [Related]
7. Adenoviral-mediated delivery of the herpes simplex virus thymidine kinase gene selectively sensitizes human ovarian carcinoma cells to ganciclovir. Rosenfeld ME; Feng M; Michael SI; Siegal GP; Alvarez RD; Curiel DT Clin Cancer Res; 1995 Dec; 1(12):1571-80. PubMed ID: 9815958 [TBL] [Abstract][Full Text] [Related]
8. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms for ganciclovir resistance in gastrointestinal tumor cells transduced with a retroviral vector containing the herpes simplex virus thymidine kinase gene. Yang L; Hwang R; Chiang Y; Gordon EM; Anderson WF; Parekh D Clin Cancer Res; 1998 Mar; 4(3):731-41. PubMed ID: 9533543 [TBL] [Abstract][Full Text] [Related]
11. Synergistic enhancement of herpes simplex virus thymidine kinase/ganciclovir-mediated cytoxicity by hydroxyurea. Boucher PD; Ostruszka LJ; Shewach DS Cancer Res; 2000 Mar; 60(6):1631-6. PubMed ID: 10749133 [TBL] [Abstract][Full Text] [Related]
12. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and accumulation of ganciclovir triphosphate in bystander cells cocultured with herpes simplex virus type 1 thymidine kinase-expressing human glioblastoma cells. Rubsam LZ; Boucher PD; Murphy PJ; KuKuruga M; Shewach DS Cancer Res; 1999 Feb; 59(3):669-75. PubMed ID: 9973216 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase. Boviatsis EJ; Scharf JM; Chase M; Harrington K; Kowall NW; Breakefield XO; Chiocca EA Gene Ther; 1994 Sep; 1(5):323-31. PubMed ID: 7584098 [TBL] [Abstract][Full Text] [Related]
15. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir. Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025 [TBL] [Abstract][Full Text] [Related]
16. Treatment of malignant gliomas with a replicating adenoviral vector expressing herpes simplex virus-thymidine kinase. Nanda D; Vogels R; Havenga M; Avezaat CJ; Bout A; Smitt PS Cancer Res; 2001 Dec; 61(24):8743-50. PubMed ID: 11751394 [TBL] [Abstract][Full Text] [Related]
17. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Qian C; Bilbao R; Bruña O; Prieto J Hepatology; 1995 Jul; 22(1):118-23. PubMed ID: 7601402 [TBL] [Abstract][Full Text] [Related]
18. (E)-5-(2-bromovinyl)-2'-deoxyuridine potentiates ganciclovir-mediated cytotoxicity on herpes simplex virus-thymidine kinase--expressing cells. Hamel W; Zirkel D; Mehdorn HM; Westphal M; Israel MA Cancer Gene Ther; 2001 May; 8(5):388-96. PubMed ID: 11477459 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of prodrugs ability to induce effective ablation of cells transduced with viral thymidine kinase gene. Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T Anticancer Res; 1996; 16(5A):2623-8. PubMed ID: 8917361 [TBL] [Abstract][Full Text] [Related]
20. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Kuriyama S; Nakatani T; Masui K; Sakamoto T; Tominaga K; Yoshikawa M; Fukui H; Ikenaka K; Tsujii T Hepatology; 1995 Dec; 22(6):1838-46. PubMed ID: 7489996 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]